RAC1 and neoplasm: Although without statistical significance, CRKI/II and RAC1 showed decreased expression tendencies in tumor tissues from Hca-P-ANXA5-shRNA1 than Hca-P-ANXA5-Control group on 10th d (Fig. 6b, c, Table 4, P = 0.309).